Global Bilirubin Blood Test Market 2019-2023 | Evolving Opportunities with Advanced Instruments and Danaher | Technavio

LONDON--()--The global bilirubin blood test market is poised to grow by USD 510.49 million during 2019-2023, progressing at a CAGR of close to 8% during the forecast period. Request Free Sample Pages

Read the 110-page research report with TOC on "Bilirubin Blood Test Market Analysis Report by Application (Infants and Adults), by Geography (North America, Europe, Asia, and ROW), and Segment Forecasts, 2019 – 2023."

The market is driven by the rising incidence of drug-induced liver injuries. In addition, the increasing number of unplanned pregnancies is anticipated to further boost the growth of the bilirubin blood test market.

The rising incidence of drug-induced liver injuries will be one of the major drivers in the global bilirubin blood test market. A few drugs can damage or limit the way the liver functions and lead to symptoms like jaundice, itching, and abdominal pain. The drug atazanavir for instance, causes the bilirubin levels to increase up to five times higher than the normal upper limit. Hence, the adoption of bilirubin blood tests to diagnose the health of the liver and to keep the bilirubin levels in check, will boost the global market during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing

Major Five Bilirubin Blood Test Market Companies:

Advanced Instruments

Advanced Instruments operates the businesses under its unified business segment. The product offered by the company is BR2 Bilirubin Stat-Analyzer. This analyzer is offered for fast and accurate results for measuring both total and direct bilirubin levels in neonates, using only a 30µL serum sample.

Danaher

Danaher operates the business under four segments, which include life sciences, diagnostics, dental, environmental & applied solutions. The company’s key offering includes UniCel DxC 800 Synchron Clinical Systems.

F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltd has business operations under the Pharmaceutical and Diagnostics segments. The product offered by the company is Bilirubin Direct Gen.2. This product is offered as an assay for in-vitro tests for the quantitative determination of direct bilirubin concentration in human serum and plasma.

Koninklijke Philips N.V.

Koninklijke Philips N.V. operates the business under three segments, which include personal health, diagnosis & treatment, and connected care & health informatics. The company’s key offering includes the BiliChek System. This product is a non-invasive, transcutaneous bilirubinometer used to measure bilirubin levels.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. operates the business under the following segments: life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. The company’s key offering in the bilirubin blood test market includes Total Bilirubin Reagents. This product determines the quantity of total bilirubin in serum samples.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Bilirubin Blood Test Application Outlook (Revenue, USD Million, 2019 - 2023)

  • Infants
  • Adults

Bilirubin Blood Test Regional Outlook (Revenue, USD Million, 2019 - 2023)

  • Asia
  • Europe
  • North America
  • ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com
media@technavio.com

Release Summary

The global bilirubin blood test market is poised to grow by USD 510.49 million during 2019-2023, progressing at a CAGR of close to 8%.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com
media@technavio.com